semaglutide fda approval mash Semaglutide, a GLP-1R agonist, is also effective for patients – MedNess FDA grants the first GLP-1
Description
Pura Collagen has launched GLPure+ and Pura Digest, expanding its product line to address the GLP-1 trend and digestive health

Lilly Zepbound / Mounjaro (tirzepatide) ~21% mean weight loss at ~72 weeks (top dose) Clear superiority vs Wegovy Growing long-term durability data Takeaway: Zepbound remains the benchmark every obesity drug must beat or meaningfully out-differentiate

UK-focused guidance.

Berberine may help with modest weight loss and blood sugar management, but delivers significantly less dramatic results than Ozempic
